Trial Details
RECRUITINGBasic Information
| Clinical ID | c861 |
|---|---|
| Identifier | NCT05923073 |
| Trial Title | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Guselkumab|DRUG: Guselkumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-03-13 |
|---|---|
| Primary Completion Date | 2027-10-27 |
| Completion Date | 2028-07-12 |